We are live on ! Find out more
HSTO

Histogen Inc. Common Stock

Delisted

HSTO was delisted on the 4th of October, 2023.

1 hedge funds and large institutions have $6 invested in Histogen Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more capital invested

Capital invested by funds: $5 → $6 (+$1)

0% more funds holding

Funds holding: 11 (0)

Holders
1
Holders Change
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
HCM
1
Highlander Capital Management
New Jersey
$6

HSTO Hedge Fund Activity: Q1 2024 in Review

1 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q1 2024, worth a combined $6 — up 20% from $5 a quarter earlier.

Fund positioning in HSTO was balanced in Q1 2024: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Histogen Inc. Common Stock (HSTO) as of Q1 2024, unchanged from Q4 2023.
  • Funds reported $6 of Histogen Inc. Common Stock stock for Q1 2024, up 20% quarter-over-quarter.
  • 0 funds opened new Histogen Inc. Common Stock positions in Q1 2024 and 0 closed out.

Based on aggregated 13F filings for Q1 2024.